The barriers to improving and changing practice are due to the rapidly evolving pace of high-level data in the treatment of brain tumors. As novel approaches are explored, further study is called for to provide more granular guidance into which patients may benefit.

Over the last three years, results have been reported on large and/or national/international clinical trials in pediatric CNS tumors and radiotherapy.

This course reviews the current state of treatment paradigms for the most common pediatric solid tumors requiring radiotherapy. The pitfalls and how to avoid them during treatment planning and best practices will be discussed.

This course will review the current state of treatment paradigms for the most common pediatric solid tumors requiring radiotherapy. The pitfalls and how to avoid them during treatment planning and best practices will be discussed.

IJROBP Journal SA-CME activity for March 1, 2019 (Volume 103, Issue 3) provides practitioners with the knowledge needed to design radiation fields and treatments for pediatric patients in a way that minimizes the risk to developing bones.

Adolescents and young adults are a growing population of patients with cancer who face unique developmental and logistical challenges in receiving oncologic care.

Pediatric radiation oncology represents a small but crucial part of clinical practice in radiation oncology.  As such the clinical practice, clinical research, and the application of newer technologies (such as proton therapy) are crucial in this setting and not likely readily available to all pr

IJROBP Journal SA-CME activity for May 1, 2018 (Volume 101, Issue 1) informs readers of the incidence and likely mechanism of brainstem injury in the context of proton therapy.   Practical recommendations are made in modifying dose limits when using proton therapy to protect children wit

Pediatric radiation oncology represents a small but crucial part of clinical practice in radiation oncology.  As such the clinical practice, clinical research, and the application of newer technologies (such as proton therapy) are crucial in this setting and not likely readily available to all pr